Researchers explore long-term adolescent vulnerability to drugsSeptember 17, 2009ATLANTA - As part of efforts to understand drug abuse, Georgia State University researchers are finding that adolescent rats appear to be less vulnerable to the long-term effects of withdrawal and relapse in certain types of drug use than rats that take the drugs in adulthood. The laboratory of Kyle Frantz, associate professor of neuroscience, studied reinstatement of drug seeking in adolescent and adult rats which were given morphine, heroin, and cocaine. Surprisingly, the younger animals were less motivated to seek the drugs after a period of abstinence than the older ones were. The younger rats also showed fewer signs of drug withdrawal. "The model is important, and the results are interesting because they suggest that younger animals do not show the same level of vulnerability as adults, at least with the drugs and conditions we've tested so far," said Frantz, whose graduate students, James Doherty and Chen Li, and technician Bonnie Williams, conducted the research with help from outstanding GSU undergraduates. Rats were first given drugs to induce urges to take more of the drug. Rats then pressed levers to receive more drugs, while receiving visual cues like lights and sound. After receiving drugs and then being withdrawn from them, researchers used the cues to see if the rats would reinstate drug-seeking behavior. Researchers found that younger rats were less likely to seek the drugs compared to the adult rats, regardless of which drug they had taken previously. By better understanding this animal model of drug intake and relapse, scientists have an opportunity to learn how the process works in humans, and may be able to apply the knowledge gained to develop better treatments. "Regardless of what people do during the teenage years, the question is whether they will transition to adult addicts who will choose drugs over responsibilities like family and work," Frantz explained. Frantz's lab has received internal grants from Georgia State University and the Medical University of South Carolina to explore the role of plasticity in the brain - the ability of the brain to change in response to different experiences - in long-term drug vulnerability. Frantz and her researchers also want to look at whether factors such as environmental enrichment are involved. "Environmental enrichment models are relatively easy to apply to the human condition. If animals are less likely to seek drugs after environmental enrichment, then drug treatment and prevention programs should include human challenges such as school, exercise, and interesting social interactions." Georgia State University |
|||||||||||||||||||||
| Related Drugs Current Events and Drugs News Articles Why can't some people give up cocaine? Drug dependency is a recurrent but treatable kind of addiction. However, not all people who are drug dependent progress in the same way once they stop taking drugs. WPI Researchers Take Aim at Hard-to-Treat Fungal Infections A team of researchers at the Worcester Polytechnic Institute (WPI) Life Sciences and Bioengineering Center at Gateway Park has developed a new model system to study fungal infections. Drug studied as possible treatment for spinal injuries Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed. Bone Implant Offers Hope for Skull Deformities A synthetic bone matrix offers hope for babies born with craniosynostosis, a condition that causes the plates in the skull to fuse too soon. Dispensing prescription drugs in 3-month supplies reduces drug costs by a third Purchasing prescription drugs in a three-month supply rather than a one-month supply has long been regarded as a way to reduce the cost of drugs for patients and third-party payers. New research from the University of Chicago quantifies the savings for the first time. New Down syndrome treatment suggested by Stanford/Packard study in mice At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. Common pain relief medication may encourage cancer growth Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells. Scientists find molecular trigger that helps prevent aging and disease Researchers at Mount Sinai School of Medicine set out to address a question that has been challenging scientists for years: How do dietary restriction-and the reverse, overconsumption-produce protective effects against aging and disease? Greater certainty in monitoring 3 therapeutic medications is facilitated by new CRMs To help bring greater certainty to the measurement of medication levels in a patient's bloodstream for three drugs with narrow therapeutic ranges, the U.S. Pharmacopeial Convention (USP) is releasing new certified reference materials (CRMs). More Drugs Current Events and Drugs News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||